|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 53 | 2018 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation | Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; BURZYKOWSKI, Tomasz; Poisson, Laila; Weinstein, John N.; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Colaprico, Antonio; Czerwinska, Patrycja; Mazurek, Sylwia; Mishra, Lopa; Heyn, Holger; Krasnitz, Alex; Godwin, Andrew K.; Lazar, Alexander J.; Stuart, Joshua M.; Hoadley, Katherine A.; Laird, Peter W.; Noushmehr, Houtan; Wiznerowicz, Maciej | Journal Contribution | A1 |
| 54 | 2018 | Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications | Rodriguez-Girondo, Mar; Salo, Perttu; BURZYKOWSKI, Tomasz; Perola, Markus; HOUWING-DUISTERMAAT, Jeanne; Mertens, Bart | Journal Contribution | A1 |
| 55 | 2018 | Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? | Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 56 | 2018 | Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results | Mackiewicz, Jacek; BURZYKOWSKI, Tomasz; Izycki, Dariusz; Mackiewicz, Andrzej | Journal Contribution | A1 |
| 57 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 58 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
| 59 | 2017 | Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approach | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | M |
| 60 | 2017 | Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question | BURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 61 | 2017 | Precision medicine needs randomized clinical trials | Saad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 62 | 2017 | Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials | Desmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 63 | 2017 | Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 64 | 2017 | An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number | Szutowicz-Zielinska, Ewa; Konopa, Krzysztof; Kowalczyk, Anna; Suszko-Kazarnowicz, Malgorzata; Duchnowska, Renata; Szczesna, Aleksandra; Ratajska, Magdalena; Sowa, Aleksander; Limon, Janusz; Biernat, Wojciech; BURZYKOWSKI, Tomasz; Jassem, Jacek; Dziadziuszko, Rafal | Journal Contribution | A1 |
| 65 | 2017 | The Analysis of Peptide-Centric Mass-Spectrometry Data Utilizing Information About the Expected Isotope Distribution | BURZYKOWSKI, Tomasz; CLAESEN, Jurgen; VALKENBORG, Dirk | Book Section | B2 |
| 66 | 2016 | Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial | Timmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 67 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 68 | 2016 | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A1 |
| 69 | 2016 | Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 70 | 2016 | Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat | Sedel, Frédéric; Chabrol, Brigitte; Audoin, Bertrand; Kaphan, Elsa; Tranchant, Christine; BURZYKOWSKI, Tomasz; Tourbah, Ayman; Vanier, Marie T.; Galanaud, Damien | Journal Contribution | A1 |
| 71 | 2016 | COMPUTATIONAL METHODS AND CHALLENGES IN HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY | CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 72 | 2016 | The Detection of Metabolite-Mediated Gene Module Co-Expression Using Multivariate Linear Models | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; SHKEDY, Ziv; Perola, Markus; Salo, Perttu; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 73 | 2016 | Adaptive Randomization of Neratinib in Early Breast Cancer | BUYSE, Marc; Saad, E.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 74 | 2016 | An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 75 | 2016 | Data-driven risk identification in phase III clinical trials using central statistical monitoring | Timmermans, Catherine; Venet, David; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 76 | 2015 | Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia | Schlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 77 | 2015 | Surrogate properties of survival endpoints in metastatic soft-tissue sarcoma: A meta-analysis. | Savina, Marion; LITIERE, Saskia; Penel, Nicolas; Rondeau, Virginie; BURZYKOWSKI, Tomasz; Toulmonde, Maud; Italiano, Antoine; Mathoulin-Pelissier, Simone; Bellera, Carine A. | Journal Contribution | M |
| 78 | 2015 | Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease | Coart, Els; GARCIA BARRADO, Leandro; Duits, Flora H.; Scheltens, Philip; van der Flier, Wiesje M.; Teunissen, Charlotte E.; van der Vies, Saskia M.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 79 | 2015 | A hidden Markov-model for gene mapping based on whole-genome next generation sequencing data | CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 80 | 2015 | A Nonhomogeneous Hidden Markov Model for Gene Mapping Based on Next-Generation Sequencing Data | ZAMANZAD GHAVIDEL, Fatemeh; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 81 | 2015 | Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma | Jacek, Mackiewicz; Aldona, Karczewska-Dzionk; Maria, Laciak; Malgorzata, Kapcinska; Maciej, Wiznerowicz; BURZYKOWSKI, Tomasz; Zakowska, Monika; Stefan, Rose-John; Andrzej, Mackiewicz | Journal Contribution | A1 |
| 82 | 2015 | PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance | Stern, Howard M.; Gardner, Humphrey; BURZYKOWSKI, Tomasz; Elatre, Wafaa; O'Brien, Carol; Lackner, Mark R.; Pestano, Gary A.; Santiago, Angela; Villalobos, Ivonne; Eiermann, Wolfgang; Pienkowski, Tadeusz; Martin, Miguel; Robert, Nicholas; Crown, John; Nuciforo, Paolo; Bee, Valerie; Mackey, John; Slamon, Dennis J.; Press, Michael F. | Journal Contribution | A1 |
| 83 | 2015 | Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers | GARCIA BARRADO, Leandro; Coart, Els; Vanderstichele, Hugo M. J.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 84 | 2015 | Differences in the Elemental Isotope Definition May Lead to Errors in Modern Mass-Spectrometry-Based Proteomics | CLAESEN, Jurgen; Lermyte, Frederik; Sobott, Frank; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 85 | 2015 | On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 86 | 2015 | Biomarker‑based surrogate endpoints | BUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Book Section | B2 |
| 87 | 2014 | Implementation Issues in Adaptive Design Trials | Danielson, Linda; Carlier, Jerome; BURZYKOWSKI, Tomasz; BUYSE, Marc | Book Section | B2 |
| 88 | 2014 | Linear mixed-effects models for central statistical monitoring of multicenter clinical trials | Desmet, L.; Venet, D.; Doffagne, E.; Timmermans, C.; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 89 | 2014 | Comparison of the Mahalanobis Distance and Pearson's χ(2) Statistic as Measures of Similarity of Isotope Patterns. | ZAMANZAD GHAVIDEL, Fatemeh; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 90 | 2014 | CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes | Kowalczuk, Oksana; BURZYKOWSKI, Tomasz; Niklinska, Wieslawa Ewa; Kozlowski, Miroslaw; Chyczewski, Lech; Niklinski, Jacek | Journal Contribution | A1 |
| 91 | 2014 | The use of the isotopic distribution as a complementary quality metric to assess tandem mass spectra results | ZAMANZAD GHAVIDEL, Fatemeh; Mertens, Inge; Baggerman, Geert; Laukens, Kris; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 92 | 2013 | Estimation of Optimally Combined-Biomarker Accuracy in the Absence of a Gold Standard Reference Test | GARCIA BARRADO, Leandro; COART, Elisabeth; BURZYKOWSKI, Tomasz | Proceedings Paper | C1 |
| 93 | 2013 | Linear Mixed Effects Models Using R. : A Step-by-Step Approach | Gałecki, Andrzej; BURZYKOWSKI, Tomasz | Book | B1 |
| 94 | 2013 | Evaluation of Progression Free Survival as a surrogate for Overall Survival for prostate cancer treatment: Software development | BIGIRUMURAME, Theophile; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; VAN SANDEN, Suzy; THILAKARATHNE, Pushpike; Dries, Joris | Conference Material | C2 |
| 95 | 2013 | Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used? | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 96 | 2013 | Immunotargeting melanoma stem cells with Hyper-IL6 modified whole cell therapeutic vaccine (AGI-101H) in patients with advanced melanoma - a joint analysis of two phase 2 studies | Mackiewicz, Jacek; Wysocki, P.; Karczewska-Dzionka, A.; Kwiatkowska-Borowczyk, E.; Kozlowska, A.; BURZYKOWSKI, Tomasz; Rose-John, S.; Wiznerowicz, M.; Mackiewicz, Andrzej | Journal Contribution | M |
| 97 | 2013 | Statistical evaluation of surrogate endpoints in clinical studies | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Book Section | B2 |
| 98 | 2013 | A Markov-chain-based regression model with random effects for the analysis of 18O-labelled mass spectra | ZHU, Qi; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 99 | 2013 | Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomic profiling experiments | EJIGU, Bedilu; VALKENBORG, Dirk; Baggerman, Geert; Vanaerschot, Manu; Witters, Erwin; Dujardin, Jean-Claude; BURZYKOWSKI, Tomasz; Berg, Maya | Journal Contribution | A1 |
| 100 | 2013 | Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis | Oba, Koji; PAOLETTI, Xavier; Bang, Yung-Jue; Bleiberg, Harry; BURZYKOWSKI, Tomasz; Fuse, Nozomu; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Pompidou, Georges; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Tsuburaya, Akira; Van Cutsem, Eric; BUYSE, Marc | Journal Contribution | A1 |
| 101 | 2013 | Markers for nutrition studies: review of criteria for the evaluation of markers | de Vries, Jan; Antoine, Jean-Michel; BURZYKOWSKI, Tomasz; Chiodini, Alessandro; Gibney, Mike; Kuhnle, Gunter; Meheust, Agnes; Pijls, Loek; Rowland, Ian | Journal Contribution | A1 |
| 102 | 2013 | Simultaneous Mapping of Multiple Gene Loci with Pooled Segregants | CLAESEN, Jurgen; CLEMENT, Lieven; SHKEDY, Ziv; Foulquié-Moreno, Maria R.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 103 | 2013 | Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis | Oba, Koji; PAOLETTI, Xavier; Alberts, Steven; Bang, Yung-Jue; Benedetti, Jacqueline; Bleiberg, Harry; CATALANO, Paul; Lordick, Florian; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-pierre; Rougier, Philippe; Sasako, Mitsuru; Sakamoto, Junichi; Sargent, Daniel; Shitara, Kohei; Cutsem, Eric Van; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 104 | 2013 | Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis | PAOLETTI, Xavier; Oba, Koji; Bang, Yung-Jue; Bleiberg, Harry; Boku, Narikazu; Bouche, Olivier; Fuse, Nozomu; Michiels, Stefan; Moehler, Markus; Morita, Satoshi; Ohashi, Yasuo; Ohtsu, Atsushi; Roth, Arnaud; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Thuss-Patience, Peter; Van Cutsem, Eric; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
Loading...
5
0
5
0
false